by Jordana Choucair | Jan 17, 2023 | Life Sciences
Pfizer Inc. said it will sell its drugs to 45 low-income countries at a not-for-profit price, including off-patent medicines like chemotherapies and oral cancer treatments. The pharmaceutical manufacturer will now offer 500 products as part of a program to increase...
by Jordana Choucair | Jan 17, 2023 | Life Sciences
The Centers for Disease Control and Prevention (CDC) said that it is “very unlikely” the Pfizer omicron booster carries a risk of stroke for seniors. According to a CDC spokesperson, the Vaccine Safety Datalink detected that 130 of the 550,000 seniors who received the...
by Jordana Choucair | Jan 17, 2023 | Mental Health
The Department of Veterans Affairs (VA) issued a new policy stipulating that U.S. military veterans who are in a suicidal crisis will be eligible for free emergency medical care from the VA. The policy, effective today (January 17), covers up to 30 days of inpatient...
by Jordana Choucair | Jan 17, 2023 | Providers
Hospitals are reducing or omitting maternity services as they attempt to shed unprofitable business lines. Hospital administrators say closures are driven by low Medicaid reimbursement rates, staffing shortages and, in some cases, declining birth rates in areas the...
by Jordana Choucair | Jan 13, 2023 | Life Sciences
Florida Governor Ron DeSantis announced a new legislative proposal that seeks to provide consumers more flexibility in buying prescription drugs and more information about their costs. The bill would specifically bar prescription benefit managers from forcing...
by Jordana Choucair | Jan 13, 2023 | M&A
Kaufman Hall released its 2022 year-end report, showing that there were 17 hospital merger and acquisition deals announced during the fourth quarter of 2022. Of those, four are set to merge two billion-dollar organizations. In total, 53 deals were announced in 2022,...
Recent Comments